Table 2.
Indicated | Slightly indicated | Not indicated | Description | |
Pancreas divisum | 83.6% | 16.7% | 0% | During therapeutic intervention |
Acute pancreatitis | 16.7% | 50% | 33.3% | Recurrent "idiopathic" acute pancreatitis |
Chronic pancreatitis | 83.3% | 16.7% | 0% | Complicated chronic pancreatitis (MPD stricture, pancreatic duct stones, chronic abdominal pain, obstructive jaundice) |
Autoimmune pancreatitis | 66.7% | 33.3% | 0% | Suspicion of autoimmune pancreatitis which has not identified by noninvasive imaging techniques |
Pancreatic neoplasia | 0% | 50% | 50% | Suspicion of pancreatic neoplasia with obstructive jaundice |
Pancreatic cystic neoplasia | 0% | 16.7% | 83.3% | In case of IPMN ERP associated with high risk of complications Pancreatic cysts and pseudocysts generally do not communicate with the pancreatic duct therefore the ERP cannot identify them |
Pancreatic injury | 100% | 0% | 0% | Suspicion of pancreatic ductal injury in stable patients Suspicion of pancreatic fistula Suspicion of fistula formation |
Postoperative pancreatic fistula | 100% | 0% | 0% |
ERP: Endoscopic pancreatography; MDP: Main pancreatic duct; IPMN: Intraductal papillary mucinous neoplasms.